Insider Trading & Executive Data
Start Free Trial
93 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Genworth Financial is a U.S.-focused insurance holding company with three reportable segments: Enact (private mortgage insurance), Long‑Term Care (LTC) insurance, and Life & Annuities, plus Corporate/Other and CareScout (an expanding fee‑based care‑matching and insurer distribution business). Enact underwrites primary mortgage guaranty insurance across all 50 states and is a material source of capital returns to the holding company (Enact returned $289M in 2024), while LTC manages large in‑force blocks and remains highly sensitive to reserve actions and regulatory rate approvals. The company’s performance is driven by underwriting results at Enact, interest‑rate impacts on investment yields and liability discounting, LTC rate action outcomes, reinsurance recoverables, and the timing of subsidiary dividends and capital contributions. Regulatory regimes (NAIC, state regulators, PMIERs, GSE eligibility) and rating agency actions are central to access to business, pricing and capital flows.
Compensation for Genworth executives is likely structured around typical Financial Services / Insurance frameworks—base salary, annual cash incentives and multi‑year equity awards (RSUs, performance shares, possibly options)—but with heavier emphasis on capital and reserve metrics specific to its business. Key performance measures that plausibly drive bonuses and long‑term awards include adjusted operating income (especially Enact operating results), return of capital from Enact to the holding company, successful LTC in‑force rate approvals and reserve adequacy, ROE/book value and total shareholder return, and maintenance of regulatory capital thresholds (PMIERs sufficiency, RBC). Given the sensitivity of results to actuarial assumptions and regulatory outcomes, executives’ pay plans will commonly feature multi‑year performance windows, deferrals and clawback provisions tied to reserve restatements or major regulatory reversals. Management’s investment in CareScout and objectives to preserve holding‑company liquidity also make milestone‑based equity or cash awards for successful scaling and capital discipline likely.
Material events for Genworth that could precede meaningful insider trades include Enact capital return announcements, LTC rate action approvals or denials, reserve remeasurements and litigation or regulatory rulings—each can quickly alter holding‑company liquidity and near‑term cash flow. Because the holding company is highly dependent on subsidiary dividends, watch for clustering of insider sales following announced capital returns or share‑repurchase activity; routine option exercises or RSU vesting tied to multi‑year plans can also generate predictable selling. Executives are subject to Section 16 reporting (Form 4) and typical blackout windows and many will use 10b5‑1 trading plans to manage timing; day traders and researchers should compare the timing/size of Form 4 filings to milestone disclosures (PMIERs updates, rate approvals, repurchases) and monitor whether trades occur inside or outside announced plans. Finally, regulatory constraints and the risk of reserve restatements mean insiders are likely to face stricter internal controls and potential clawbacks—sales shortly before adverse reserve or regulatory news merit closer scrutiny.